Key facts
- Neo Modulus’s last known valuation is $154.3M (Jul 2021).
- It has raised $79.7M; the latest was Later Stage VC ($41.1M) in Jan 2025.
- Notable investors include Shenzhen Capital Group, SND Ventures Group, CDH Investments, 10Fund, Clivia Capital — 9 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 9 names
- ·Watchlist + deal alerts for Neo Modulus
- ·The full record, as it builds
Funding rounds
No funding rounds for Neo Modulus are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Neo Modulus
Researcher and developer of regenerative implantable medical devices. The company focuses on developing regenerative implantable medical devices to achieve guided tissue regeneration, and guided bone regeneration in trauma patients, enabling medical users with solutions for bionic organ manufacturing and preparation technology.
- Sector
- Healthcare
- HQ
- Suzhou, China
- Founded
- 2017
- Website
- neomodulus.com/
- Ownership
- Privately Held (backing)
Neo Modulus doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Neo Modulus shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Neo Modulus in its N-PORT filings yet. We sweep new filings monthly.